The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...
FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...
Ozzy Osbourne shares a heartbreaking update on his Sirius XM radio show about his Parkinson's diagnosis. The rocker tells his fans, 'I can’t walk, but you know what I was thinking over the holidays?
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
A Huntsville-based biotechnology company has secured $10 million in funding to begin the trial of a new way to deliver medication to advanced Parkinson’s disease patients.
Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces a program ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
Traditional deep brain stimulation surgery can take up to 10 hours to complete, with the patient wide awake. This robotic ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback